2013
DOI: 10.1016/j.ijantimicag.2013.06.012
|View full text |Cite
|
Sign up to set email alerts
|

What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
93
2
9

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 135 publications
(105 citation statements)
references
References 27 publications
1
93
2
9
Order By: Relevance
“…Finally, the full susceptibility to colistin observed in E. coli is valuable both for poultry and human concerns, since this agent is widely used in poultry production and represents a last-resort treatment in human medicine (Livermore, 2004). In accordance with our results, colistin resistance seems to be extremely rare (<1%) in healthy animals, including poultry, in Europe (Kempf et al, 2013b). The resistance to the majority of antimicrobials tested in this study is known to be conferred by the acquisition of foreign resistance genes through horizontal transfer, which usually emerges in the presence of antimicrobial selective pressure and involves not only pathogenic but also commensal bacteria (Schwarz et al, 2006;van Hoek et al, 2011).…”
Section: Discussionsupporting
confidence: 88%
“…Finally, the full susceptibility to colistin observed in E. coli is valuable both for poultry and human concerns, since this agent is widely used in poultry production and represents a last-resort treatment in human medicine (Livermore, 2004). In accordance with our results, colistin resistance seems to be extremely rare (<1%) in healthy animals, including poultry, in Europe (Kempf et al, 2013b). The resistance to the majority of antimicrobials tested in this study is known to be conferred by the acquisition of foreign resistance genes through horizontal transfer, which usually emerges in the presence of antimicrobial selective pressure and involves not only pathogenic but also commensal bacteria (Schwarz et al, 2006;van Hoek et al, 2011).…”
Section: Discussionsupporting
confidence: 88%
“…Despite this extensive use in veterinary medicine, the resistance rate to colistin in E. coli strains recovered from healthy animals remains Ͻ1% in many European countries (62). However, resistance to colistin has increasingly been reported (10%) among porcine-pathogenic E. coli strains in Belgium (63), and the emergence of resistance has been described for cattle (64).…”
Section: Use In Veterinary Medicinementioning
confidence: 99%
“…Field studies have shown that it is used primarily for pigs including group treatments and prevention of diarrhoea caused by Escherichia coli and Salmonella spp., as first-choice treatments for neonatal diarrhoea caused by E. coli in piglets [51,52] and veal calves [53] as well as for the therapy of mild colibacillosis in poultry [54]. Studies conducted in Belgium describe how colistin has been used for indications other than those for which it is authorised, e.g., respiratory disease, peritonitis [53] and streptococcal infections [52].…”
Section: Veterinary Medicinementioning
confidence: 99%